🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the pharmacokinetics (PK) of AL-33...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-09-11
Trial ID
NCT03277755
Treatments Being Tested
This is an open-label, two-group, fixed-sequence study to evaluate the effe...
Status
Completed
Location
Biotrial
Start Date
2015-07-31
Trial ID
NCT02512562
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of AL-...
Status
Completed
Location
CAP Research Ltd
Start Date
2015-10-31
Trial ID
NCT02569710
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK) of a sin...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-13
Trial ID
NCT02894905
Treatments Being Tested
The main purpose of this study is to evaluate the durability of Sustained v...
Status
Terminated
Location
LAIR Centre
Start Date
2017-04-10
Trial ID
NCT03099135
Treatments Being Tested
The purpose of this study is to assess the relative bioavailability of sing...
Status
Terminated
Location
Celerion
Start Date
2017-02-20
Trial ID
NCT03059303
The purpose of this study is to evaluate the efficacy (proportion of subjec...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-09
Trial ID
NCT02765490
Treatments Being Tested
The purpose of this study is to investigate the steady-state pharmacokineti...
Status
Completed
Location
Multiple Locations
Start Date
2016-05
Trial ID
NCT02824315
Treatments Being Tested
This randomized, double-blind, placebo-controlled, 3-part study will assess...
Status
Completed
Location
Biotrial
Start Date
2014-12-31
Trial ID
NCT02339207
Treatments Being Tested
The main purpose of this study is to assess the effect of a single suprathe...
Status
Completed
Location
Celerion
Start Date
2017-05-12
Trial ID
NCT03155893
Treatments Being Tested